4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-006668
President and CEO gave up 3,675 shares (to pay taxes)
- President and CEO acquired 10,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-02-03 | Option exercise | +10,800 | 932,578 | D: show line 1 in the form | ||
| Walker Neal President and CEO | 2020-02-03 | Shares withheld for taxes | −3,675 | $1.28 | $4,704 | 928,903 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-02-03 | Option exercise · Restricted Stock Units | −10,800 | 21,600 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…